$67.36 0.52 (+0.78%)
2/10/2012 4:00 PM

Amgen, Inc. (NASDAQ:AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Featured Broker Partners


Advertisement